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a b s t r a c t
Aims: To compare the effects on health-related quality of life (HRQoL) of a 2-year interven-
tion with a low-fat diet (LFD) or a low-carbohydrate diet (LCD) based on four group-meetings
to achieve compliance. To describe different aspects of taking part in the intervention
following the LFD or LCD.
Methods: Prospective, randomized trial of 61 adults with Type 2 diabetes mellitus. The SF-36
questionnaire was used at baseline, 6, 12 and 24 months. Patients on LFD aimed for 55–60
energy percent (E%) and those on LCD for 20 E% from carbohydrates. The patients were
interviewed about their experiences of the intervention.
Results: Mean body-mass-index was 32.7  5.4 kg/m2 at baseline. Weight-loss did not differ
between groups and was maximal at 6 months, LFD: 3.99  4.1 kg, LCD: 4.31  3.6 kg
( p < 0.001 within groups). There was an increase in the physical component score of SF-36
from 44.1 (10.0) to 46.7 (10.5) at 12 months in the LCD group ( p < 0.009) while no change
occurred in the LFD group ( p < 0.03 between groups). At 12 months the physical function,
bodily pain and general health scores improved within the LCD group ( p values 0.042–0.009)
while there was no change within the LFD group.
Conclusions: Weight-changes did not differ between the diet groups while improvements in
HRQoL only occurred after one year during treatment with LCD. No changes of HRQoL
occurred in the LFD group in spite of a similar reduction in body weight.
# 2014 The Authors. Published by Elsevier Ireland Ltd. This is an open access article under
the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
§ Trial registry number: NCT01005498 at ClinicalTrials.gov.
§§ This study has been presented as an abstract at EASD 24 September 2013, Barcelona, Spain.
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Several studies have shown that both individuals with obesity
[1–3] and Type 2 diabetes [4,5] have lowered health-related
quality of life (HRQoL) in comparison with normal-weight
individuals. There is also an inverse relationship between
degree of obesity measured with BMI and HRQoL [6]. Both the
physical component score (PCS) and mental component score
(MCS) of the Short Form 36 (SF-36) show lower values in
obesity, which indicates lower HRQoL, but the difference is
more prominent in the PCS [7]. In the Australian Diabetes,
Obesity and Lifestyle study [8] obesity at baseline was related
to a decreased HRQoL, when followed during 5 years, and low
HRQoL was also a predictor of weight gain during the follow-
up period. While the scores are lower for patients who have
developed diabetic complications [9], a lowered score can also
be found in patients with newly diagnosed diabetes without
any diabetes-related complications [10] which shows that it is
not only a result of such complications. The relationship is
dual as low scores on the SF-36 have been found to predict the
risk of later development of Type 2 diabetes, cardiovascular
disease and mortality [11]. In the study by Williams et al., low
PCS on the SF-36 was related to further increase in
cardiovascular mortality in patients with diabetes and a
similar association was found for the MCS. There are thus
interactions between HRQoL and both Type 2 diabetes and
obesity.
Intentional weight-loss in both obesity and in Type 2
diabetes leads to improvements in cardiovascular risk factors,
and has also been found to improve HRQoL [12,13]. In the
SHIELD study improvement of quality of life was found in the
participants with Type 2 diabetes who had lost weight during
the last 12 months compared with respondents reporting
weight gain [14]. Also weight reduction by gastric bypass,
Roux-en-Y gastric bypass surgery, has been shown to improve
HRQoL when followed up after 2 years postoperatively [15,16].
Some studies have prospectively compared the effect of
different diet regimens in patients with Type 2 diabetes
mellitus, with the main focus being change of body weight and
of cardiovascular risk factors. There are very few reports on
HRQoL in such comparative studies. In a study Brinkworth
et al. compared the effects on Profile of Mood States, Beck
Depression Inventory, and Spielberger State Anxiety Invento-
ry score in overweight or obese participants randomized to
low-fat or low-carbohydrate diet, and found greater improve-
ment of psychological mood in the low fat group [17]. However,
diabetes was an exclusion criterion in the study by Brinkworth
et al.
We performed a randomized study confined to patients
with Type 2 diabetes mellitus to compare glycaemic control
and also of weight-loss and cardiovascular risk factors of a
low-carbohydrate diet with that of a traditional low-fat diet.
The results on body weight, glycaemic control and other
cardiovascular risk factors have been previously reported [18].
In contrast to most previous studies, the patients randomized
to the low-carbohydrate diet were not advised to avoid
saturated fat. The interventions were based on four group
meetings with duration of 60 min each for the first year and no
further group meetings during the remaining 12 months weregiven. Both reduction of energy intake and changes of the
macronutrient composition might, by not well-known mech-
anisms, affect HRQoL [19]. In these further analyses of our
study, the aim was to compare effects on health-related
quality of life during a low-carbohydrate diet compared with a
traditional low-fat diet in patients with Type 2 diabetes
mellitus. A second aim was to describe different aspects from
taking part of the intervention following the low-fat or low-
carbohydrate diet.
2. Materials and methods
The methods have been described before [18]. In short patients
with Type 2 diabetes were included in the study, which was
conducted at two primary health care centres in southeast
Sweden. The patients were randomized either to a low-
carbohydrate diet or to a traditional low-fat diet, both with a
caloric content of 1600 kcal for women or 1800 kcal for men.
Randomization was not stratified, and was based on drawing
blinded ballots. The low-carbohydrate diet had an energy
content where 50 E% was fat, 20 E% carbohydrates and 30 E%
protein. The low-fat diet had a nutrient composition that was
similar to what is traditionally recommended for treatment of
Type 2 diabetes in Sweden with 30 E% fat (less than 10 E%
saturated fat), 55–60 E% carbohydrates and 10–15 E% protein.
No information was given to change the level of physical
activity of the participants.
Investigations of anthropometrics and laboratory tests
were performed at baseline and at 6, 12 and 24 months, and
patients were also asked to fill-out questionnaires on health-
related quality of life (SF-36) at these time-points. Diet records
were also performed at these 4 visits with one additional
recording at 3 months.
The generic Short Form-36 (SF-36) questionnaire designed
to measure individuals HRQoL in clinical practice, research,
health policy evaluations and general population surveys was
used. The 36 item questionnaire comprise eight health
domains; physical functioning (PF, 10 items), role limitations
due to physical problems (RP, 4 items), bodily pain (BP, 2
items), general health (GH, 5 items), vitality (VT, 4 items), social
function (SF, 2 items), role limitations due to emotional
problems (RE, 3 items), and mental health (MH, 5 items) and
one single item rating health status over one year [20]. Each
domain is separately scored and transformed in values
between 0 and 100 where a higher score indicates higher
HRQoL. The combined Physical component score (PCS) and
Mental component score (MCS) were calculated. Both reliabil-
ity and validity has been extensively evaluated under Swedish
conditions [21]. No imputation of data was done in the case of a
missing questionnaire.
The participants were interviewed following a semi-
structured interview guide with eight questions regarding
different aspects of taking part of the intervention following
the low-fat or low-carbohydrate diet. The answers were
written down by the interviewer during the interview and
the text was analyzed using conventional content analysis
following Hsieh and Shannon [22]. At 12 months, but not at
other time points, they also answered 3 VAS-scales about
appetite and satiety.
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Statistical calculations were done with PASW 20.0 software
(SPSS Inc., Chicago, IL, USA). Linear correlations were
calculated, as stated in the text. Comparisons within and
between groups were done with Student’s paired and
unpaired 2-tailed t-test or in the case of questionnaires by
Wilcoxon and Mann–Whitney tests. Mean (SD) is given unless
otherwise stated. Statistical significance was considered to be
present at the 5% level ( p  0.05). ANOVA with repeated
measures was used for calculations of the changes during the
total study duration.
2.2. Ethics
The study was approved by the Regional Ethics Committee of
Linko¨ping and performed in accordance with the Declaration
of Helsinki. Written informed consent was obtained from all
participating subjects. The study was registered with trial
number NCT01005498 at ClinicalTrials.gov.
3. Results
3.1. Total study population
The study population and the flow chart of the study have
been previously described in detail [18]. In total 61 patients
entered the study, and at baseline the SF-36 questionnaires
were completed by 30 patients in the low-fat group and by 30
patients in the low-carbohydrate group. The questionnaire
was answered by 22 patients at 6 months, 28 patients at 12
months and 29 patients at 24 months in the LFD group, while
the corresponding figures for the LCD group were 23, 27 and 25,
respectively.
The mean age in the low-fat group was 62.7  11 years and
there were 13 men and 18 women having a diabetes-duration
of 8.8  6.2 years. Corresponding figures for the low-carbohy-
drate group were 61.2  9.5 years, 14 men and 16 women and a
known diabetes-duration of 9.8  5.5 years. Age, gender
composition and known duration of diabetes did not differ
between the groups (all p > 0.05).
Among the patients who answered the SF-36 questionnaire
body weight in the LFD group was 98.8  21.6 kg at baseline,
93.7  19.3 kg at 6 months, 92.9  18.7 kg at 12 months and
95.0  21.5 kg at 24 months. Corresponding figures for the LCD
group were 91.4  18.9 kg, 84.8  18.6 kg, 88.4  19.3 kg and
85.2  16.1 kg. There were no differences in weight reduction
between these groups (at 6 months: LFD group: 4.5  4.5 kg,
LCD group: 4.5  3.6 kg, p = 0.99, at 12 months: LFD group:
3.4  4.3 kg, LCD group: 3.1  4.1 kg, p = 0.84, at 24 months
LFD group: 3.4  4.5 kg, LCD group: 3.2  4.3 kg, p = 0.85).
Weight reduction within either group was significant between
baseline and the same time points ( p < 0.001).
The results of HRQoL are described in Table 1. There was no
difference in baseline values in any of the domains between
the low-fat and low carbohydrate groups. The low-carbohy-
drate showed improvements in the Physical function, Bodily
Pain, General Health and Vitality domains of the SF-36 at 12
months compared to baseline ( p values 0.042–0.009). Incontrast to this, no change was observed in the low-fat group
at any time during the study. The change from baseline to 12
months showed improvements in Bodily Pain and General
Health in the low-carbohydrate group in comparison with the
low-fat group ( p = 0.017 and 0.022, respectively). At 12 months
there was also an improvement in the combined Physical
Component Score (PCS) in the low-carbohydrate group
compared to baseline ( p = 0.009) and also compared to the
low-fat group ( p = 0.028) (Fig. 1). We also recalculated the
results based on the patients who were judged to be fully
compliant with the prescribed diet by the criteria of intake of
fat > 40 E% together with carbohydrates < 40 E% for the LCD
and fat < 40 E% together with carbohydrates > 40 E% for the
LFD, and this did not change the main results (data not
shown).
In multiple linear regression analyses using change in
PCS as dependent variable and changes in BMI and HbA1c as
independent variables, the change in PCS remained associ-
ated with the change in BMI in the LFD group at 6 and 12
months (b = 0.872, p = 0.001, respectively b = 0.679,
p < 0.0005) and the change in HbA1c in the LFD group at 6
months (b = 0˙496, p = 0.028). There were no associations in
changes in the LCD group in the same analyses. There were
no associations between regain of body weight from 6 to 12
months and changes of SF-36 variables during the same
period (data not shown). Changes in Mental Component
Score (MCS) showed no associations to changes in BMI and
HbA1c in linear regression analysis at 6 and 12 months, for
both groups.
The VAS scale ‘‘I will succeed/not succeed with this diet’’
showed similar results 6.5 (2.6) in the low fat group and 7.4 (2.7)
in the low carbohydrate group at 12 months ( p = 0.95). The VAS
scale ‘‘I am often hungry/satisfied’’ showed similar results 6.6
(2.7) in the low fat group and 7.2 (2.7) in the low carbohydrate
group ( p = 0.81). The VAS scale ‘‘I have craving for food/not
craving for food’’ also showed similar results 6.4 (3.1) in the
low fat group and 6.2 (3.4) in the low carbohydrate group
( p = 0.38).
3.2. Interview
Each transcript was read from beginning to end several times
and key words or phrases were highlighted and coded. Four
categories emerged during this process that describes differ-
ent aspects of taking part in the intervention.
3.3. Big and small changes
Participants in both diet-groups did not find the necessary
changes very burdensome. In the low-fat group it was
common to have been eating quite similar before taking part
of the study. When eating out it could be hard to follow the diet
strictly.
The participants that found the changes difficult were only
found in the low carbohydrate-diet group, and potatoes were
mentioned as hard to restrain from as well as change from
low-fat to high fat products. Participants in this group also
found it difficult to substitute pasta and potatoes as well as
cookies and snacks within the diet provided. It was hard to eat
so much fatty products.
Table 1 – SF-36 at baseline, 6, 12 and 24 months in 30 patients with Type 2 diabetes during treatment with low fat diet and in 30 patients with Type 2 diabetes during
treatment with low carbohydrate diet (means (SD); Wilcoxon signed rank test and Mann–Whitney U test). The questionnaire was answered by 22 patients at 6 months, 28

































Low fat 79.8 (20.0) 84.5 (12.1) 0.65 83.8 (15.7) 0.10 81.6 (17.7) 0.62 0.48 0.27 0.38 0.49
Low carb 77.7 (19.3) 79.4 (15.6) 0.15 83.6 (18.2) 0.009 78.7 (19.7) 0.12 0.004
Role
Physical
Low fat 78.1 (35.9) 84.5 (26.8) 0.55 87.5 (27.6) 0.34 67.8 (42.7) 0.13 0.68 0.89 0.87 0.042
Low carb 79.5 (29.7) 70.5 (39.1) 0.78 78.7 (33.0) 0.64 66.3 (43.7) 0.13 0.60
Bodily Pain Low fat 69.3 (27.1) 66.2 (22.3) 0.49 65.7 (26.5) 0.59 61.6 (28.34) 0.11 0.85 0.017 0.12 0.12
Low carb 61.0 (23.0) 61.0 (25.0) 0.95 71.4 (22.1) 0.021 60.6 (25.6) 0.72 0.031
General
Health
Low fat 62.5 (21.1) 67.7 (18.2) 0.41 63.3 (18.4) 0.46 66.1 (23.4) 0.51 0.85 0.022 0.88 0.40
Low carb 63.2 (22.3) 63.5 (25.6) 0.29 70.7 (22.7) 0.031 63.8 (26.7) 0.55 0.031
Vitality Low fat 65.0 (20.3) 71.0 (17.4) 0.66 66.9 (22.9) 0.83 67.8 (23.9) 0.49 0.39 0.12 0.75 0.87
Low carb 62.2 (19.9) 65.5 (22.4) 0.16 69.8 (19.3) 0.042 61.2 (23.9) 0.92 0.09
Social
Function
Low fat 91.7 (14.8) 93.2 (18.0) 0.57 93.8 (15.4) 0.54 88.3 (20.3) 0.18 0.94 0.96 0.69 0.73
Low carb 90.8 (15.7) 87.0 (23.7) 0.72 92.1 (15.2) 0.34 88.0 (19.9) 0.39 0.41
Role
Emotional
Low fat 83.3 (33.6) 90.5 (26.1) 0.71 91.7 (26.6) 0.10 85.1 (34.0) 0.86 0.50 0.67 0.73 0.67
Low carb 90.8 (17.6) 78.8 (35.0) 0.20 91.4 (21.9) 0.73 93.9 (19.6) 0.91 0.06
Mental
Health
Low fat 83.3 (15.8) 84.5(17.0) 0.80 83.7 (17.4) 0.57 82.3 (16.9) 0.78 0.40 0.93 0.59 0.14
Low carb 80.1 (13.4) 81.6 (17.) 0.28 83.2 (10.6) 0.54 81.0 (10.7) 0.78 0.35
PCS Low fat 45.3 (10.5) 45.8 (8.2) 0.88 45.9 (8.9) 0.86 43.6 (10.5) 0.17 0.23 0.028 0.44 0.35
Low carb 44.1 (10.0) 43.2 (12.4) 0.10 46.7 (10.5) 0.009 41.4 (14.0) 0.77 0.011
MCS Low fat 51.7 (9.8) 53.5 (10.1) 0.50 52.8 (9.5) 0.64 52.0 (9.4) 0.91 0.43 0.64 0.58 0.28
Low carb 51.7 (7.2) 50.0 (13.0) 0.33 52.6 (5.3) 0.23 53.1 (4.2) 0.48 0.66
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Fig. 1 – Physical component score (PCS) and mental component score (MCS) of SF-36 at baseline, 6, 12 and 24 months in 30
patients with Type 2 diabetes during treatment with low fat diet (LFD) and in 30 patients with Type 2 diabetes during
treatment with low carbohydrate diet (LCD) (means (SD); Wilcoxon signed rank test and Mann–Whitney U test). The
questionnaire was answered by 22 patients at 6 months, 28 patients at 12 months and 29 patients at 24 months in the low
fat group while the corresponding figures for the low carbohydrate group were 23, 27 and 25, respectively.
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to be ‘‘dull’’ and wanted a more varied food selection. They
also felt guilty when not strictly following the diet.
3.4. Gains
Both diet-groups mentioned expected gains in health with
their diet.
In the low-fat group the diet was described as easy to
follow, tasty and cheap in price.
The low-carbohydrate group described that they felt less
hungry and were less prone to sweets.
3.5. Strategies
Both diet-groups mentioned difficulties when eating in other
people’s homes or when going to restaurants and during
holidays. Strategies mentioned were to eat very little of the
food not allowed. During Christmas it was easy to find
alternatives to eat.
3.6. Support
Both diet-groups mentioned that it was supportive if the
whole family could follow the same diet. In the low-
carbohydrate group the families sometimes choose to prepare
two different meals at a time.
4. Discussion
In obesity, with or without coexisting Type 2 diabetes mellitus,
intentional reduction of body weight is considered to improve
health-related quality of life [1,3,4] and it was therefore of
interest that no such effect could be found according to SF-36
after 6 months which was the time when the reduction of body
weight in both diet groups was maximal in the present study.Later, after 12 months, improvements of HRQoL were found
only in the low carbohydrate group. The improvements
related to physical function and to vitality and general health,
while the domains relating to mental health showed no
change. In the SF-36, a difference of five points in an individual
domain or 2–3 points in PCS or MCS are considered clinically
significant [23,24]. The changes of these subscales and of PCS
that were found in our study are thus considered to be
clinically significant. A lowered energy intake of 1600 kcal for
women and 1800 kcal for men was prescribed for both study
groups, but the main focus in the study was the comparison of
a diet with a low carbohydrate intake with a low fat diet, which
is the traditional diet recommended for treatment of Type 2
diabetes mellitus. In recent years there has been increased
interest in the use of low-carbohydrate diets in the treatment
of diabetes, but we are not aware of any previous study that
has addressed the effects on HRQoL measured by SF-36 in
patients with Type 2 diabetes mellitus randomized to a low-
carbohydrate diet.
In obese subjects, lower values of the scales of the SF-36
relating to physical function than in normal weight and
overweight individuals are found [7], and it is therefore likely
to see an improvement in these scales during an intervention.
There are different possible mechanisms for the improve-
ments of these during the study including reduction of body
weight in the patients, who had a mean BMI of 32 when
entering the study, improvement of glycaemic control, but
also the change of macronutrients per se. Our finding that there
was no change in SF-36 after 6 months, when reduction of
body weight was maximal in both groups, argues against this
being only an effect of weight reduction. A limitation of our
study is that not all patients filled out the questionnaire at this
time while the answering frequency was good at 12 months.
This makes the 6 months results more uncertain. Another
limitation is that a few patients were not fully compliant with
their diets throughout the study but calculations excluding
these patients showed similar SF-36 results. Furthermore the
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the improvement in HRQoL occurred only in the LCD group. In
the LFD group associations were found between changes of PCS
and both changes of BMI and HbA1c, while no such associations
were found in the LCD group which might suggest that other
factors, possibly the diet per se, might have been of importance
for the improvements found in PCS in the LCD group.
In this study no scale specifically addressing anxiety and
depression was used, but we could not find support for that the
low carbohydrate diet caused deterioration of the mental scores
of SF-36. The MCS was unchanged in both study groups at all
times evaluated. As mentioned Brinkworth et al. [17] studied the
effect of a LCD and a LFD for one year on quality of life, but they
did not include SF-36. They reported short-term results up to 8
weeks showing very rapid, already after 2 weeks, and similar
improvements in mood for both groups [25]. When the patients
were followed for a longer period, up to one year, some of the
scores returned towards baseline in the LCD group, and a
significant difference emerged compared with the LFD group
[17]. These results might seem contradictory to our results but
there are major differences between this study and ours. A
major difference was that a very low carbohydrate diet aiming
at only 4% of the energy intake consisting of carbohydrates was
used while we prescribed a more moderate carbohydrate
restriction to 20 E% and reached 26–31 E% according to the diet
registrations. Another difference was that in their study obese
participants were included but diabetes was an exclusion
criterion. Also the reduction of body weight was greater, almost
14 kg at the termination of the study, which might have been a
consequence of more intense lifestyle treatment regimen. From
the results of our study it can be concluded that aiming for more
moderate reduction of carbohydrates is feasible in patients with
Type 2 diabetes in routine primary care, and has no adverse
effects on the mental aspects of HRQoL. This is also in
agreement with a study by Davis et al. [26] who found a
tendency towards improvement of the anxiety and worry items
of the Diabetes-39 questionnaire during a diet intervention in
Type 2 diabetes. There are very few studies of short duration
that have compared the effects of different diets on HRQoL and
mood in obesity. Yancy et al. [27] found that treatment with a
low carbohydrate diet improved the MCS in SF-36 in overweight
volunteers. In a small 3-week study d’Anci et al. found worse
performance on memory-based tasks and less confusion during
a low-carbohydrate diet compared with a low-fat diet. The
study was performed in overweight or obese women. In our
study we did not measure acute effects on HRQoL, but in
contrast found no changes in any of the groups in SF-36 after 6
months, which might suggest that longer treatment is neces-
sary to obtain improvements of HRQoL.
In the LookAHEAD study, changes of depressive symptoms
were evaluated at baseline and after one year with the Beck
Depressive Inventory [12]. The lifestyle intervention in the
patients who had Type 2 diabetes was based on a low fat diet in
combination with increased physical activity. It was conclud-
ed that intentional weight loss was not associated with the
precipitation of depressive symptoms, but instead appeared to
protect against this occurrence.
The interview suggests that both study groups made
relevant changes of their previous diet to follow the prescribed
diet during the study. In general, they did not find thesechanges difficult but the need to reduce intake of potatoes
which is a main carbohydrate-rich ingredient of Swedish diet
(It is eaten in average 0.7 times a day according to a survey
presented by the National Food Agency) was pointed out as
troublesome by the LCD group. Reduction of carbohydrate
intake when changing to a very low carbohydrate diet has
been described as troublesome [28] and even the moderate
reduction of carbohydrates in our study caused some
problems when changing from low-fat to high-fat products,
as well as substitute cookies and snacks. A wish for more
varied food recipes was pronounced by both groups.
Both study groups mentioned hopes that their diet would
incur health benefits and felt guilty when not strictly adhering
to it. Benefits for the low fat diet was that it was tasty and
cheap in price while feeling less hungry and easier to avoid
sweets were mentioned in the low carbohydrate group, but it
should be noted that the questions based on VAS-scales, that
were administered only at 12 months, showed no difference
between the study groups on satiety and hunger. Both study
groups mentioned difficulties following the diet when social-
izing with others i.e. during holidays or eating out. Eating only
small amounts of ‘‘forbidden’’ food items were mentioned as a
way to handle these situations. When eating at their own
home it was more convenient if the whole family could eat the
same food. When implementing and sustaining dietary
change social relationships within and without the household
has an impact on compliance. It seems important to involve
the family in these changes [29].
In conclusion, weight-changes did not differ between the
diet groups while improvements in HRQoL only occurred after
one year during treatment with LCD. No changes of HRQoL
occurred in the LFD group in spite of a similar reduction in
body weight.
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